Table 3.
Kaplan-Meier survival analyses followed by Breslow Generalized Wilcoxon pairwise post-hoc comparison of survival curves (Fig. 2) across treatments
| 1ppb TMX | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Treatments | Caffeine + TMX | Gallic Acid + TMX | Kaempferol + TMX | p-coumaric acid + TMX | TMX | |||||
| χ 2 | P | χ 2 | P | χ 2 | P | χ 2 | P | χ 2 | P | |
| Gallic acid + TMX | 231.13 | < 0.001 | ||||||||
| Kaempferol + TMX | 525.07 | < 0.001 | 95.37 | < 0.001 | ||||||
| p-coumaric acid + TMX | 154.27 | < 0.001 | 6.97 | 0.008 | 187.42 | < 0.001 | ||||
| TMX | 753.88 | < 0.001 | 204.16 | < 0.001 | 29.83 | < 0.001 | 340.08 | < 0.001 | ||
| Sucrose only | 801.55 | < 0.001 | 228.09 | < 0.001 | 38.21 | < 0.001 | 370.24 | < 0.001 | 0.52 | 0.47 |
| 10ppb TMX | ||||||||||
| Gallic acid + TMX | 0.04 | 0.8 | ||||||||
| Kaempferol + TMX | 135.62 | < 0.001 | 167.70 | < 0.001 | ||||||
| p-coumaric acid + TMX | 1.99 | 0.159 | 3.24 | 0.072 | 194.57 | < 0.001 | ||||
| TMX | 49.82 | < 0.001 | 58.83 | < 0.001 | 386.94 | < 0.001 | 33.11 | < 0.001 | ||
| Sucrose only | 251.5 | < 0.001 | 264.85 | < 0.001 | 716.58 | < 0.001 | 226.59 | < 0.001 | 90.44 | < 0.001 |
Bold font indicates statistical significance.